KEGG: bcz:BCE33L4336
Bacillus cereus is a Gram-positive, facultatively anaerobic, spore-forming bacterium belonging to the Bacillus cereus sensu lato group, which includes other closely related species such as B. anthracis and B. thuringiensis . It has a genome size of approximately 5,335 kb with a G+C content of ~35% . The bacterium contains numerous membrane proteins that play critical roles in virulence, antimicrobial resistance, and cellular physiology. BCE33L4336, classified as an UPF0756 family membrane protein, represents one of the many membrane-associated proteins encoded in the B. cereus genome.
B. cereus produces various virulence factors including enterotoxins such as hemolysin BL (HBL), non-hemolytic enterotoxin (NHE), enterotoxin FM (EntFM), and cytotoxin K (CytK) . These virulence factors contribute to the pathogen's ability to cause food poisoning and more severe infections including pneumonia, bacteremia, endophthalmitis, and central nervous system infections .
When culturing B. cereus for membrane protein studies, researchers should consider the following methodological approach:
Growth media composition:
Brain Heart Infusion (BHI) broth provides excellent yields for B. cereus cultivation
Luria-Bertani (LB) medium supplemented with 0.5% glucose can enhance growth
Defined minimal media may be used when specific nutrient limitations are required
Growth conditions:
Temperature: 30-37°C for mesophilic strains (note that psychrotrophic strains grow below 10°C but not at 37°C)
pH: 6.0-7.0
Aeration: Moderate shaking (150-200 rpm) for aerobic growth
Growth phase: Late exponential phase typically provides optimal membrane protein expression
For BCE33L4336 expression studies, monitoring growth using optical density measurements at 600 nm (OD600) is recommended, with harvest typically occurring at OD600 of 0.8-1.0 for optimal membrane protein yield.
Several expression systems can be employed for recombinant production of BCE33L4336, each with distinct advantages:
| Expression System | Advantages | Disadvantages | Recommended for BCE33L4336 |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, well-established protocols, economical | May form inclusion bodies, potential toxicity | Initial expression trials |
| E. coli C41(DE3)/C43(DE3) | Designed for toxic membrane proteins | Lower yields than BL21 | When standard strains fail |
| Bacillus subtilis | Native-like membrane environment, efficient secretion | More complex genetic manipulation | Higher-quality functional studies |
| Cell-free expression | Avoids toxicity issues, direct incorporation into liposomes | Expensive, lower yields | Difficult-to-express proteins |
For BCE33L4336, a methodological approach would include:
Construct design with appropriate fusion tags (His6, MBP, or SUMO) to aid solubility and purification
Codon optimization for the selected expression host
Incorporation of inducible promoters (IPTG-inducible T7 or arabinose-inducible araBAD)
Temperature optimization (often lowering to 16-20°C post-induction)
Addition of membrane protein-specific chaperones or foldases when necessary
Membrane proteins like BCE33L4336 present solubility challenges. The following methodological approaches can enhance solubility:
Fusion partner screening:
MBP (maltose-binding protein) fusion at N-terminus
SUMO fusion for enhanced folding
Thioredoxin fusion for disulfide bond formation
Expression condition optimization:
Reduce expression temperature to 16-20°C post-induction
Use lower inducer concentrations (0.1-0.5 mM IPTG instead of 1 mM)
Extend expression time (16-24 hours) at lower temperatures
Additives to expression media:
Glycerol (5-10%) to stabilize hydrophobic domains
Specific metal ions if the protein contains metal-binding domains
Osmolytes like sucrose (5%) or betaine (1 mM)
Solubilization approaches:
Screen detergent panels (DDM, LDAO, LMNG) for optimal extraction
Employ bicelles or nanodiscs for native-like lipid environments
Consider amphipols for enhanced stability
Reliable detection and quantification of BCE33L4336 can be achieved through multiple methods:
Immunological techniques:
Western blotting using anti-His tag antibodies (if His-tagged) or custom antibodies against BCE33L4336
ELISA for quantitative analysis in complex samples
Immunofluorescence for localization studies
Mass spectrometry approaches:
LC-MS/MS for identification and relative quantification
Selected reaction monitoring (SRM) for absolute quantification
MALDI-TOF for rapid screening
Fluorescence-based methods:
Activity-based assays:
If enzymatic activity is known, functional assays can provide indirect quantification
Ligand binding assays if binding partners are identified
For bacterial capture and detection methodologies, researchers have successfully employed membrane-associated proteins as biointerfaces in lateral flow assays, which could potentially be adapted for BCE33L4336 studies .
A systematic approach to studying the structure-function relationship of BCE33L4336 includes:
Structural analysis methods:
X-ray crystallography (challenging for membrane proteins)
Cryo-electron microscopy for higher-resolution structures
NMR spectroscopy for dynamic studies
Computational modeling based on homologous proteins
Functional characterization approaches:
Site-directed mutagenesis of predicted functional residues
Deletion mapping of domains
Cross-linking studies to identify interaction partners
Electrophysiology if channel/transport functions are suspected
Correlation methodologies:
Structure-guided mutagenesis followed by functional assays
Molecular dynamics simulations to predict conformational changes
Evolutionary analysis to identify conserved functional residues
In vivo relevance studies:
Knockout/knockdown studies in B. cereus
Complementation assays with mutant variants
Virulence assessment in infection models if BCE33L4336 is implicated in pathogenicity
While specific functions of BCE33L4336 are not directly described in the provided literature, membrane proteins in B. cereus often contribute to virulence through several mechanisms:
Potential roles in toxin secretion:
Possible involvement in adhesion and invasion:
Antimicrobial resistance connection:
B. cereus produces β-lactamases conferring resistance to most β-lactam antibiotics
Membrane proteins can function as efflux pumps or modify membrane permeability to antibiotics
Over 82% of B. cereus isolates show resistance to β-lactam antibiotics, while fewer are resistant to cefotetan (13.59%) and imipenem (0.27%)
Experimental approaches to investigate BCE33L4336 virulence roles:
Gene knockout studies followed by virulence assessment
Protein localization during infection using fluorescently tagged variants
Transcriptomics to determine expression patterns during infection stages
Protein-protein interaction studies to identify virulence-associated binding partners
Membrane proteins like BCE33L4336 potentially interact with host immune systems in several ways:
Pattern recognition receptor (PRR) interactions:
As a membrane protein, BCE33L4336 may contain pathogen-associated molecular patterns (PAMPs)
These PAMPs could be recognized by host Toll-like receptors (TLRs) or other PRRs
Such interactions may trigger inflammatory responses or be involved in immune evasion
Methodology for studying immune interactions:
Recombinant protein stimulation of immune cells (macrophages, dendritic cells)
Cytokine profiling following exposure to purified BCE33L4336
Pull-down assays to identify direct immune receptor binding
In vivo infection models comparing wild-type and BCE33L4336-deficient strains
Potential immunomodulatory functions:
Inhibition of complement activation
Interference with phagocytosis
Modulation of cytokine production
Alteration of antigen presentation
Purification of membrane proteins like BCE33L4336 requires specialized approaches:
Membrane isolation and solubilization:
Differential centrifugation to isolate membrane fractions
Detergent screening panel (typically 8-10 different detergents)
Solubilization optimization (detergent:protein ratio, temperature, time)
| Detergent Class | Examples | Optimal Concentration | Best For |
|---|---|---|---|
| Mild non-ionic | DDM, LMNG | 1-2% for extraction, 0.02-0.05% for purification | Maintaining native structure |
| Zwitterionic | LDAO, Fos-choline | 1-2% | Higher extraction efficiency |
| Bile salt derivatives | CHAPS, cholate | 0.5-1% | Versatile extraction |
Affinity chromatography strategies:
Immobilized metal affinity chromatography (IMAC) for His-tagged protein
Optimization of imidazole concentrations (10-40 mM wash, 250-500 mM elution)
On-column detergent exchange if needed
Secondary purification steps:
Size exclusion chromatography to remove aggregates and ensure monodispersity
Ion exchange chromatography for further purification
Lipid addition during purification to maintain stability
Quality control assessments:
Dynamic light scattering to confirm monodispersity
Circular dichroism to verify secondary structure
Thermal shift assays to optimize buffer conditions
Crystallization of membrane proteins presents significant challenges. For proteins like BCE33L4336, these methodological approaches have proven useful:
Traditional vapor diffusion with modifications:
Detergent screening is critical (typically requires testing 6-10 different detergents)
Lipid cubic phase (LCP) crystallization for maintaining native-like environment
Bicelle-based crystallization combining lipids and detergents
Addition of specific lipids that co-purify with the protein
Crystal optimization strategies:
Antibody fragment (Fab) co-crystallization to increase polar surfaces
Fusion with crystallization chaperones (T4 lysozyme, BRIL)
Surface entropy reduction through mutation of flexible loops
Screening various truncation constructs to remove disordered regions
Alternative structural approaches when crystallization fails:
Cryo-electron microscopy (particularly suitable for larger membrane proteins)
NMR spectroscopy for smaller membrane proteins or specific domains
Hydrogen-deuterium exchange mass spectrometry for dynamics and interactions
Molecular modeling based on homologous structures
To determine the physiological function of BCE33L4336, researchers should consider these methodological approaches:
Genetic manipulation strategies:
Gene knockout using CRISPR-Cas9 or homologous recombination
Conditional expression systems to study essential genes
Complementation studies to confirm phenotypes
Site-directed mutagenesis of predicted functional residues
Phenotypic characterization:
Molecular interaction studies:
Pull-down assays to identify protein-protein interactions
Two-hybrid screens for interaction partners
Co-immunoprecipitation from native membranes
Cross-linking studies followed by mass spectrometry
Comparative analysis with other Bacillus species:
Functional comparison with homologs in related species like B. anthracis and B. thuringiensis
Complementation studies across species
Evolutionary analysis of protein conservation